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Stimulated kidney tubular epithelial cells express membrane associated
and secreted TNFa. Tumor necrosis factor-alpha (TNFa) is a pleiotro-
pic, pro-inflammatory peptide cytokine which promotes immune renal
injury, and participates in T cell activation. It is produced by macro-
phages, T cells, and some non-hematopoietic cells, and is cytotoxic in
picogram quantities. As renal tubular epithelial cells (TEC) bearing
MHC class II (Ia) antigens and adhesion molecules (ICAM-l) can act as
immune accessory cells, the ability of TEC to produce costimulatory
cytokines could augment TEC accessory capacity in vivo. We report
that transformed TEC express low levels of TNFa in response to LPS
or IL-I a as a secreted product and as a cytotoxic membrane associated
molecule displayed on the cell surface. Surface labelling and immuno-
precipitation studies of TEC detect a number of bands including a
prominent 26 kD protein, which is the predicted size of TNFa precur-
sor. TNFa mRNA transcripts were also detected by in situ hybridiza-
tion in cortical tubules of C3H/FeJ mice injected with LPS, demonstrat-
ing the capacity of normal tubular epithelial cells to express TNFa in
vivo. This report demonstrates for the first time the ability of kidney
tubular cells to express TNFa protein and that membrane associated
TNFa is not limited to hematopoietic cells. The function of small
amounts of TNF displayed on the surface of tubular cells may be
amplified by the abundance of these cells within the renal cortex, and
may allow TEC to modulate immune responses within the kidney
during inflammation.
Tumor necrosis factor-alpha (TNFa) is a potent cytokine
produced by a variety of cell types. In addition to macrophages
in which it was initially described, T cells, and several non-
hematopoietic cells can also express mRNA for TNFa [1—8].
Minute quantities of this cytokine produce measurable effects in
many cell types, and it is apparent that with the growing overlap
that exists between cells which can produce TNFa and those
affected by its presence, the physiology of TNFa is extremely
complex [9].
The pro-inflammatory role of TNFa is well established and
includes chemotactic attraction, prostaglandin release, synthe-
sis of pro-coagulant factors, induction of other cytokines, and
upregulation of MHC and adhesion molecules such as ICAM-I
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[3, 7, 9—13]. Recent evidence has suggested that TNFa may also
function as a costimulatory factor for T cells [14—16]. The
expression of TNFa is normally tightly regulated to avoid
systemic toxic injury. In some instances, most notably septic
shock, dysregulation occurs, and the release of milligram quan-
tities of TNFa systematically results in a deleterious or even
fatal outcome for the host [9]. It is likely that most physiological
effects of TNF result from very low levels of this cytokine.
Several mechanisms may localize TNFa effects, including the
production of small quantities, natural antagonists [17—19] or an
association of TNFa with cell membranes [1, 2, 9, 20—22].
TNFa producing cells may employ one or more of these
strategies to localize effects.
The primary function of renal tubular epithelial cells (TEC),
the most abundant cell type in the kidney cortex, is solute and
water transport. Recently we reported that TEC are also
capable of immune accessory cell function since they can
express MHC class II (Ia) antigens and adhesion molecules
such as ICAM-l, and present antigen to T cells [7, 10, 23].
These studies prompted us to examine the ability of TEC to
generate costimulatory cytokines. Our previous study reported
that TEC can be stimulated by lipopolysaccharide (LPS) or
interleukin-la (IL-la), to express mRNA for TNFa [7]. In the
present study, we demonstrate for the first time that trans-
formed TEC express secreted and membrane forms of TNFa.
The membrane association and limited quantities of TNFa
produced suggest a local role for this molecule within the
kidney. The novel demonstration of cytotoxic membrane TNFa
on TEC may have important implications in understanding the
action of TNFa in renal disease.
Methods
Materials
Tissue culture media and reagents were obtained from Gibco
(Grand Island, New York, USA), and chemicals were obtained
from Sigma Chemical Co. (St. Louis, Missouri, USA). Recom-
binant murine TNFa and IFN-y were provided by Genentech
(South San Francisco, California, USA). Recombinant murine
IL-la was donated by Hoffmann-LaRoche (Nutley, New Jer-
sey, USA). Lipopolysaccharide (LPS, S. minnesota) was from
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Calbiochem (La Jolla, California, USA). Rabbit anti-mouse
TNFa antisera was provided by Dr. A. Cerami (New York,
NY, USA) [24] and Dr. S. Kunkel (Ann Arbor, Michigan,
USA). Anti-mouse TNFa mAb (TN3-19.l2) was provided by
Dr. R.D. Schreiber (St. Louis, Missouri, USA) [25], and
YN1/l.7.4 (anti-murine ICAM-1) was prepared as previously
described [261.
Cell cultures and cell lines
The establishment of mouse C3H/FeJ (Cl, Cl.l) and MRL-
lpr (M3.1) derived clonal cell lines by transformation of proxi-
mal tubular cells with origin-deficient SV4O DNA is described in
detail elsewhere [7]. These epithelial cells were grown in
modified K! medium (50:50mixture of DMEM and Ham's F12
medium), containing 5% fetal calf serum (FCS) and hormonal
additives. P388D1 cells were obtained from the American Type
Culture Collection (Rockville, Maryland, USA) and grown
according to the protocol provided.
RNA preparation and Northern blot analysis
Total RNA was isolated from confluent monolayers of trans-
formed TEC with a single-step acid guanidium isothiocyanate-
phenol-chloroform extraction method [27]. Total RNA (25 g)
was denatured with 1 M glyoxal and 50% dimethylsulfoxide,
electrophoresed through a 1.2% agarose gel, and transferred
onto Gene Screen Plus nylon membranes (New England Nu-
clear, Boston, Massachusetts, USA). The RNA was UV light
crosslinked, and blots were prehybridized with 1 mrt EDTA,
0.5 M NaH2PO4 (pH 7.2) and 7% sodium dodecyl sulfate (SDS)
at 65°C. A specific 250 bp cDNA insert encoding murine TNFa
was isolated by plasmid digestion with Rsal [28, 29]. Probes
were radiolabeled by primer extension using random hexanu-
cleotides [30]. Blots were hybridized for 16 to 24 hours at 65°C
and washed twice at 65°C with 1 mri EDTA, 40 mrvt NaH2PO4
(pH 7.2), and 5% SDS for 30 to 60 minutes, and twice with 1 mM
EDTA, 40 mrvi NaH2PO4 (pH 7.2), and 1% SDS for 30 to 60
minutes at 65°C. After hybridization the blots were exposed to
Kodak X-AR film at —70°C for 4 to 10 days. Blots were
reprobed with f3-actin to ensure that approximately equal
amounts of RNA were loaded in each lane. Steady-state mRNA
transcript levels were quantified using scanning densitometry
(Biosoft, Milltown, New Jersey, USA). In blots with high
background due to long autoradiography times, background
counts were subtracted in each lane from corresponding spe-
cific TNF signal. The ratio of TNFa//3-actin was then calculated
to standardize RNA levels and allow quantitative comparison of
values between stimulated and unstimulated cells.
In situ hybridization
C3H/FeJ mice aged four to five months were given 50 g of
LPS i.v. via the tail vein, and tissue was obtained two hours
later. Kidneys were fixed in 4% paraformaldehyde, perfused
with 30% sucrose and then snap frozen. To synthesize ribo-
probes, a 700 bp EcoRl/Sstl fragment of cDNA for murine
TNFa (Genentech) was subcloned into a pBluescript vector
(Stratagene, La Jolla, California, USA) allowing the generation
of both sense and antisense RNA probes. Probes were labelled
using 355-rUTP (Amersham). Kidney cryosections (6 tm) were
digested with proteinase K (1 g/ml), refIxed with 4% paraform-
aldehyde, and acetylated with acetic anhydride. Probes (5 x iO
cpm) were added to a hybridization solution (containing final
concentrations of 10% dextran sulfate, 0.24 M NaC1, 4 mi
Tris-CI, pH 7.5, 0.8 mrt EDTA, 0.4x Denhardt's, 200 g/ml
yeast tRNA, 40% formamide), which was added to each slide,
and incubated at 42°C overnight. Unhybridized probe was
washed from the slides at 42°C, and then digested with RNase.
Dried slides were dipped in NTB2 emulsion (Kodak), devel-
oped 7 to 10 days later, fixed, and counter stained with
hematoxylin-eosin. Antisense probes hybridized to TNFa
mRNA, while sense probes served as negative controls. In
some experiments, grains were counted over six fields using a
lOOx oil immersion lens and 10 squares of a grid marking a total
area of 1 mm2 for each field, on coded slides by two investiga-
tors.
Flow cytometry
Unstimulated Cl cells and cells treated with IL-la (100
ng/ml), LPS (1 tg/ml) and/or IFN-y (250 U/mI) were pipetted
vigorously to detach from culture plates, washed with HBSS,
and then co-labelled with rabbit anti-mouse TNFa antisera and
biotinylated rat anti-mouse ICAM-l (YN1/1.7.4) as primary
antibodies. Fluorescein-conjugated affinity-purified goat anti-
rabbit IgG F(ab')2 fragment and phycoerythrin-streptavidin
(Becton-Dickinson, San Jose, California, USA) were used as
secondary steps. Cells were analyzed with a Becton-Dickinson
flow cytometer.
Western blot
Recombinant mouse TNFa was electrophoresed on an SDS
polyacrylamide gradient gel (10 to 20%) under reducing condi-
tions [31] and blotted onto nitrocellulose using standard tech-
niques. Blots were incubated with rabbit anti-mouse TNFa
antisera (1:600), followed by goat anti-rabbit alkaline phos-
phatase (1:3000) and developed with 0.3 mg/mI p-nitro blue
tetrazolium chloride plus 0.15 mg/mI 5-bromo-4-chloro-3-in-
dolyl phosphate-toluidine salt.
Radioiodination and immunoprecipitation of cell surface
TNFa
Cells were grown in K! media, stimulated with LPS (1 j.gIml)
for 12 hours, and washed with HBSS. Approximately 1 x l0
cells in phosphate buffered saline (PBS) were surface labelled
with 1 mCi of Na'25! (Amersham, Arlington Heights, Illinois,
USA) using immobilized lactoperoxidase conjugated to Sepha-
rose-4B beads. The reaction was stopped with 1 mM cysteine,
and all steps were then carried out at 4°C. Cells were then lysed
in I ml of extract buffer containing 1% Nonidet P-40 (NP-40), 50
mM KC1, 10 mri NaC1, 1 m EDTA, 50 mrs KH2PO4 buffer (pH
7.5), 2 mr.i phenylmethylsulfonyl fluoride (PMSF), and 2 tg/ml
of antipain, leupeptin and pepstatin A. Debris was removed by
centrifugation at 15,000 rpm for 20 minutes and the lysate was
precleared with Protein-A Sepharose for 16 hours. The extract
was divided into two equal aliquots and 20 pi of rabbit anti-
mouse TNFa antisera or preimmune rabbit serum was added
for one hour, followed by precipitation with Protein-A Sepha-
rose beads for 30 minutes. The immunoprecipitate was washed
three times with lysis buffer and then twice with PBS pH 7.2.
Buffer containing dithiothreitol (DTT) and SDS was added to
the samples, and after boiling for five minutes, 5 l was run in
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a 12% polyacrilamide gel. The gels were fixed, dried and
autoradiography with an intensifying screen was carried out at
—18S
Metabolic labelling of TEC with 3H-leucine
Confluent CI cells were incubated for 16 hours in leucine free
RPM!- 1640 media supplemented with 3H-leucine (New England
Nuclear, Boston, Massachusetts, USA) at 16 jxCilml, in the
presence or absence of LPS (1 jsglml) or IL-la (100 ng/ml).
Cells were removed from the plates by the addition of HBSS
without Ca /Mg and vigorous pipetting, and lysed as
above. Precleared lysates were equally divided and treated with
20 l of anti-TNFa antisera alone, or antisera which had been
pre-incubated with I g of unlabelled recombinant murine
TNFa. Immunoprecipitation and electrophoresis were as
above, the gel was fixed, treated with Amplify (Amersham
Corp) for fluorography before drying and autoradiography.
TNFa L929 cell bioassay
TNF activity in culture supernatants was determined in a
standard cytotoxicity assay using L929 mouse fibroblasts
(ATCC, Rockville, Maryland, USA). Briefly, 1.5-2 x IO L929
cells/well were plated in 96-well flat bottom plates (Costar,
Cambridge, Massachusetts, USA). Supernatants were added in
triplicate to wells containing an equal volume of RPM! media
with 5 jxg/ml of actinomycin D. Plates were incubated for 18 to
24 hours at 37°C, media was removed, and 50 xg of MTT
(3-(4,5-dimethylthiazol-2y1)-2,5-diphenyl tetrazolium bromide)
solution was added to each well. After an additional four hours
of incubation, an equal volume of 10% SDS was added to the
wells. Optical densities were read on a 96-well microtiter plate
reader at 570 to 650 nm (Dynatech). Serial dilutions of murine
recombinant TNFa (0.9 pg/well to 250 pg/well) were used to
produce a standard curve [32, 33].
To determine cell surface associated TNF cytotoxicity, we
modified the L929 cell method. TEC were grown in 96-well flat
bottom plates to confluence in groups containing triplicate
wells, washed and incubated in the presence or absence of LPS
(1 xgIml) or IL-la (100 ng/ml) for 4 to 12 hours. Monolayers
were then fixed with 1% paraformaldehyde for one hour. Cells
were incubated for 12 hours after fixation, and washed three
times with media prior to use in experiments. Plates were
examined with an inverted phase contrast microscope (Nikon)
to exclude disruption of the monolayers. In some experiments,
monolayers were further incubated at 37°C with rabbit anti-
TNFa antisera, pre-immune serum (1:20) or fresh media for one
hour, and washed before L929 cells (2 x l0) were layered onto
the monolayers. MTT was added for four hours as above, and
a cytotoxicity index was derived from 1/OD7065ønm. The
antisera used for blocking experiments were able to neutralize
250 to 500 pg/mI of recombinant mouse TNFa activity at a
dilution of 1:180 [24].
Limulus endotoxin assay
Samples of medium including all additives, were assayed for
LPS contamination by the Limulus amebocyte assay (Associ-
ates of Cape Cod, Wood's Hole, Massachusetts, USA) accord-
ing to the protocol provided. The lower limit of detection for
this assay was 0.125 EU/mI and the lowest concentration of
Fig. 1. TNFa mRNA is induced in CI cells by IL-lix andLPS. Lane 1:
unstimulated P388D1 cell RNA as positive control (0.507); lane 2:
unstimulated Cl cells (0.005): lane 3: IL-la (100 ng/ml) for 4 hours
(0.204); lane 4: LPS (I pg/mI) for 4 hours (0.150). Lane 1 contains 5 g
and lanes 2 to 4 contain 25 g of total RNA. Autoradiography was for
10 days accounting for increased background. The blot was also
reprobed for /3-actin. The ratio of TNFa//3-actin indicated in parenthe-
ses was calculated by scanning densitometry, as in methods.
LPS standard used that provided a positive result contained 25
pg of LPS (E. coli 0113).
Statistics
Statistical analysis, where applicable, was performed using
Statview SE+ (Abacus Concepts, Berkley, California, USA).
Differences between groups were compared by one way anal-
ysis of variance and unpaired t tests. All results are expressed
as mean SEM.
Results
TEC expression of TNFa mRNA is less than macrophages
Cl cells were incubated with IL-la or LPS for four hours and
total RNA was probed for TNFa. RNA for a positive control
was also extracted from P388D1 cells which are macrophage
derived tumor cells known to express TNFa mRNA [34].
Figure 1 demonstrates Cl cells have detectable TNFa mRNA
within four hours of stimulation. However, considering Cl
lanes have been loaded with 25 g of total RNA, and that 5 xg
of total RNA extracted from P388D1 cells demonstrated a
markedly larger TNF/f3-actin ratio, it is apparent that TEC
express TNFa mRNA at much lower levels than macrophages.
TEC expression of TNFcx mRNA is increased by
cycloheximide
We have previously shown that TNFa can be specifically
induced in TEC by either LPS or IL-la, and not by IFN-y
which can activate TEC and increase the expression of Ia
antigens and ICAM-l [7, 10]. In some cell types, the expression
of TNFa mRNA may be increased by blocking protein synthe-
sis [8]. To determine if protein synthesis was required for
transcription of TNFa mRNA in TEC, we treated Cl cells with
TNF(
13-actin
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Fig. 2. TNFa mRNA is superinduced in TEC by cycloheximide. Lane
1: unstimulated Cl cells (0.003); lane 2: IL-la (100 ng/ml) for 3 hours
(0.034); lane 3: IL-la for 12 hours (0.009); lane 4: IL-la and cyclohex-
imide (5 sg/ml) for 12 hours (0.457); lane 5: LPS (1 g/ml) for 12 hours
(0.156); lane 6: LPS and cycloheximide for 12 hours (0.538); lane 7:
cycloheximide alone for 12 hours (0.203); lane 8: indomethacin (l0 M)
for 4 hours followed by fresh media for 12 hours (0.021); lane 9:
indomethacin followed by IL-la for 12 hours (0.042). Autoradiography
was for 4 days. Results are representative of 3 experiments. The blot
was also reprobed for /3-actin, and the ratio of TNFaJ/3-actin indicated
in parentheses was calculated for each sample by scanning densitome-
try.
cycloheximide [35]. In this experiment, TNFa mRNA was seen
with IL-la but not LPS stimulation at three hours (Fig. 2).
However, concurrent stimulation with IL-i a or LPS and treat-
ment with 5 xg/ml of cycloheximide caused a marked increase
of TNFa mRNA, indicating that blocking protein synthesis
caused increased mRNA transcription, or that stabilization of
transcripts had occurred. Cycloheximide alone resulted in a
slight increase of mRNA. This "superinduction" was not
unique to Cl cells as similar results were observed for M3.1
cells concurrently treated with cycloheximide (not shown).
The levels of TNFa mRNA at 3 to 12 hours in Figure 2 are
reduced from what we have observed in the past with TEC
stimulated by individual cytokines. While this may have been
due in part to shorter autoradiography exposure times that we
used to emphasize "superinduction", we have noted a gener-
alized decreased inducibility of TNFa in some of our cell lines
with prolonged passaging. There is no evidence by morphology
or growth characteristics that these transformed cells have
undergone senescence. One possibility was inhibition of TNF
by endogenous production of prostaglandins (PG). As TEC are
capable of PGE2 synthesis [7] which has been shown to
downregulate TNFa production in other cell types [36], we
pretreated Cl cells with indomethacin (l0— M) for four hours
prior to stimulation to block prostaglandin release (Fig. 2) [37].
However we observed only a slight augmentation in TNFa
expression in pretreated IL-i a stimulated cells. Another possi-
bility is densitization of Cl cells by chronic exposure to
undetectable but functional levels of LPS [38, 39]. Since cyclo-
oxygenase inhibition may not totally overcome LPS desensiti-
zation in monocytes, it is possible that low levels of endotoxin
in the media were sufficient to cause desensitization of tubular
cells and subsequent reduced TNFa expression.
Tubular epithelial cells express TNFa mRNA in vivo
To examine if tubular epithelial cells could similarly express
TNFa mRNA in vivo, C3H/FeJ mice were injected with LPS
Fig. 3. Cortical tubular cells of C3H/FeJ mice express TNFa mRNA in
response to LPS. In situ hybridization was with TNF specific 35S
antisense riboprobes. Background grain density was variable between
experiments and results shown are from an experiment separate from
those detailed in Table 1. (A) Grain density in tubules was low in
untreated mice and was equivalent to non-hybridizing sense controls in
treated mice. Glomeruli are indicated by arrows. (B) Following LPS
treatment, cortical tubules had marked increases in grain density,
indicating TNFa transcripts. Autoradiography was 10 days. Magnifica-
tion is approximately 500x.
and cortical tubular expression of TNFa mRNA was assessed
by in situ hybridization (Fig. 3 A,B). To quantify this response,
grain counts were obtained in two additional experiments.
Grain counts using sense riboprobe controls which should not
hybridize to mRNA, were comparable to background counts
over non-tissue areas or counts over medulla. Treatment of the
tissue with RNAse prior to hybridization reduced grain counts
to background in stimulated animals (not shown). Even with
variation in the background counts, LPS stimulation increased
grain counts over cortical tubular cells 2- to 10-fold as compared
to unstimulated controls or sense controls (P < 0.01; Table I).
In sections where medulla could clearly be identified, there was
a twofold difference in cortical areas (P < 0.01), suggesting that
TNFa expression may be related more to tubular cells than
collecting ducts. Firm conclusions would require co-localiza-
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Table 1. LPS in
i
duces cortical tubular expression of T
n situ hybridization in C3H/FeJ mice
NF mRNA by
LPS treatment
Grain countsa
Cortical
tubules' Glomeruli Medulla Backgroundc
Exp I
Antisensed
Sense —
19 2 17 2 NAC
24 2 22 2 NA
18 2
21 2
Antisense +
Sense +
212 lS 83 7 NA
22 2 22 2 NA
16 2
21 2
Exp 2
Antisense +
Sense+
113 7 113 9 78 3
71±2 71±2 57±2
56 3
58±2
C3H/FeJ mice were given LPS IV and kidney tissue was probed with
antisense and sense TNF specific riboprobes. Grain counts were
compared between treated and non treated mice, and between different
areas of the kidney. Results are from 2 experiments.
grains were counted over cells in a 1 mm2 grid, in 6 separate areasb periglomerular cortical tubules counted
grain counts over non-tissue areas was variable between experi-
ments
d antisense = complementary to TNF mRNA
C NA = medulla not visible in coronal sections of kidney pole
P < 0.01 from background, medulla, and unstimulated mice
Table 2. TEC supernatants contain cytotoxic TNF activity
Sample
Time
hours
TNFa activity
pg/mi
Media alone
Unstimulated
IL-la
LPS
IL-la and LPS
6
12
6
12
6
0
8.9 I
21±5
33±6
28±4
15±2
32 2
L929 cells were incubated with fresh media, culture supernatants
from unstimulated C1.l cells, and supernatants from cells stimulated
with either LPS (Wml) or IL-la (100 ng/ml). Results are means of
triplicate samples from two experiments.
tion with a proximal tubular cell marker, which is technically
difficult with low level mRNA's.
Stimulated TEC secrete low levels ofTNFa into culture
supernatants
To examine whether mRNA was translated into biologically
active protein, supernatants were tested for activity in a stan-
dard L929 cell TNF cytotoxicity bioassay. TEC stimulated with
IL-la or LPS for 4 to 12 hours resulted in significant (P < 0.05)
but low levels of TNF activity (Table 2). Quantification of the
specific TNFa activity present in the supernatants indicated
that the maximum levels of approximately 35 pg/mI produced
by TEC were 25 to 30 times less than what has been reported for
macrophages, and is consistent with our TNFa mRNA results
[36]. Not all non-hematopoietic TNF producing cells are capa-
ble of expressing large amounts of this cytokine. Paneth cells in
gut epithelium have detectable mRNA levels but similarly
produce low levels of TNFa, indicating that there is a wide
spectrum of synthesis capacity among various cells types [5].
Interestingly, the 24-hour culture supernatant from unstimu-
Fig. 4. Anti-TNFa antisera identifies 17 kD TNFa protein. Recombi-
nant mouse TNFa was loaded in lane 1(10 ng) and lane 2 (5 ng), and
analyzed by Western blot as in Methods. Size markers (kD) and solvent
front (SF) are indicated.
lated TEC in one experiment (Table 2), demonstrated cytotoxic
activity which was above the media controls. The significance
of this is unclear but may suggest a basal secretion of TNFa,
which can be further increased with stimulation. In this regard,
influence by media LPS levels below the limits of detection by
Limulus assays has not been excluded.
TEC express cytotoxic membrane associated TNFa
Since we could detect only low levels of TNFa in culture
supernatants, we were interested if TNFa produced by TEC
remained associated with the cell membrane. Anti TNFa anti-
sera which specifically identifies 17 kDa recombinant mouse
TNFa was used for FACS analysis and immunoprecipitation
studies (Fig. 4). In FACS analysis, Cl cells co-labelled with
anti-TNFa and anti-ICAM-1 antibodies showed some basal
expression of both molecules in unstimulated cells (Fig. 5).
After 16 hours of stimulation with IL-I or LPS, there was a
predominant increase in TNFa surface expression, in contrast
to IFN-y stimulation, which is known to cause a predominant
increase in TEC ICAM-l [10]. Interestingly, co-incubation of
IFN-y with IL-la or LPS markedly increased ICAM-l expres-
sion but TNFa expression remained at basal levels.
To determine if the surface proteins identified by anti-TNFa
antisera had biological activity, we examined TEC monolayers,
rigorously fixed with paraformaldehyde for one hour, for their
ability to lyse TNF-sensitive L929 cells (Fig. 6). Monolayers
offer an advantage over using membrane fragments, as only the
external cell surface portion of the TNFa molecule can interact
with target cells. In four experiments, monolayers stimulated
with IL-la or LPS for 4 to 12 hours had a greater cytotoxicity
index (inverse of optical density) than unstimulated cells (P <
0.05). Furthermore, when the monolayers were incubated with
anti-TNF antisera prior to the L929 cells, cytotoxicity was
reduced to baseline values (P < 0.05). The data shown are
representative of two experiments performed using blocking
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Fig. 5. TEC express surface TNFa in response
to IL-la (100 ng/rnl) and LPS (1 pg/m!) but not
IFN-y (250 U/mI). Cl cells were co-labelled with
anti-mouse TNFa antisera and anti ICAM-l
antibodies (b-g), and assessed for surface
expression by FACS as in methods. Panels: (A)
without primary antibodies, (B) unstimulated
cells, (C) IL-la, 16 hours, (D) LPS, 16 hours, (E)
IFN-y, 16 hours, (F) IFN-y and IL-la, 16 hours,
(G) IFN-y and LPS, 16 hours.
Fig. 6. TEC express cytotoxic membrane
associated TNF. Symbols are: () unstimulated;
(LI) LPS + non-immune serum; (PA) LPS + anti-
TNF; () IL-i + non-immune system; (PA) IL-I
+ anti-TNF. Cl and M3.l cell monolayers were
fixed after incubation with LPS (1 g/ml), IL-la
(100 ng/ml) or fresh media for 4 hours.
Monolayers were then treated with rabbit anti-
mouse TNFa antisera or pre-immune rabbit sera
and then assessed for their ability to lyse L929
cells. Results are means of triplicate samples and
are representative of two experiments. Similar
cytotoxicity was seen when monolayers were
incubated with indomethacin (l0— M) for 4 hours
prior to stimulation. Values marked by *
represent differences (P < 0.05) from
unstimulated controls.
antisera. Similar results were obtained with M3.1 cell monolay-
ers (not shown). In contrast, incubation of the monolayers with
pre-immune rabbit serum did not reduce the level of cytotox-
icity and was equivalent to adding fresh media alone. Interest-
ingly, the addition of excess amounts of antisera to stimulated
monolayers never reduced cytotoxicity to below baseline val-
ues. This suggests that any basally-expressed surface form of
TNF was not cytotoxic to L929 cells. To reduce the potential
effect of endogenous PGE synthesis and overcome desensitiza-
tion by low levels of endotoxin, monolayers were also pre-
treated with indomethacin prior to layering of L929 cells (Fig.
6). Although the general level of cytotoxicity was increased
with this pre-treatment, a similar pattern of cytotoxicity was
obtained with cells stimulated with IL-i or LPS, and anti-TNF
antisera blocked cytotoxicity to baseline.
Cl cells express multiple forms of TNFa with stimulation
Labelling with 3H-leucine and immunoprecipitation of lysates
from TEC stimulated with IL-Ia or LPS (Fig. 7) showed
prominent bands at approximately 40 to 45 kD. The presence of
reduced but similar bands in unstimulated cells again suggests
there is a basal expression of some form of TNFa in vitro. The
bands that were detected could be competitively blocked by
excess unlabelled recombinant murine TNFa, indicating that
the immunoprecipitate was antigenically related to TNFs. With
a 3H-leucine label, we did not detect any bands corresponding
to the 26 kD membrane associated TNF found in other cells [2,
20, 24]. To clarify the nature of TNFa related surface proteins
on TEC, Cl cells were stimulated with LPS for 12 hours and
cells were surface radioiodinated (Fig. 8). Using this technique,
a major band was seen at 26 kD, and as well, bands at —-45, and
—70 kD. No bands were observed using pre-immune rabbit
serum in a control immuno-precipitation. A TNF related band
of —17 kD size could not be clearly distinguished in the gel front
of either surface or metabolically-labelled cell lysates.
Discussion
Tumor necrosis factor (TNFa) is a pro-inflammatory cyto-
kine which is elevated during renal allograft rejection and
murine autoimmune lupus nephritis [40, 41]. Furthermore, the
administration of exogenous TNFa accelerates kidney damage
in NZB/W mice [421, and thus the production of TNFa by
intrinsic renal cells could contribute to immune renal injury. We
now report that TEC synthesize a biologically active, cytotoxic
form of TNFa, which is both secreted and associated with the
cell surface as an integral membrane protein. Given the direct
apposition of TEC to other intrinsic renal cells, the pleiotropic
nature of TNFa, and the fact that 80 percent of the renal cortex
is comprised of proximal TEC, we believe that TNFa produced
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Fig. 7. Immunoprecipitation of CI cell extracts is blocked by rTNFa.
Cl cell monolayers were incubated with media alone (lanes 1, 2), LPS
(1 zgIml) (lanes 3, 4) or IL-lis (100 ng/ml) (lanes 5, 6) and labelled with
3H-Ieucine. Cell extracts were then analyzed with SDS-PAGE (10 to
20%). Lanes 1, 3 and 5 were precipitated with anti-TNFa antisera.
Lanes 2, 4, and 6 were precipitated with anti-TNFa antisera which was
previously incubated with an excess of unlabelled rTNFn. Size markers
(kD) are indicated. Autoradiography was for 12 days.
by TEC may play an important role in modulating immune
responses within the kidney.
The expression of TNFa by TEC can be increased by both
LPS and IL-la, which also cause TNFa release by other cell
types [7, 9, 121. The response to IL-la is of note in relation to
autoimmune nephritis, since IL-I produced by infiltrating
mononuclear cells is elevated in the kidneys of mice with lupus
nephritis [40, 43, 44]. Overall, the amount of TNFa synthesized
by TEC appears to be small, when compared to macrophages
which can produce massive amounts [6, 36]. However, the
demonstration of cytotoxicity using the L929 cell bioassay
which is sensitive to picogram quantities, emphasizes the
potent biological effect of even small quantities of TNFa. The
presence of membrane TNF on TEC may serve to increase
bioactivity locally by focusing its effect on contacting cells. The
overall importance of secreted and membrane TNFa by TEC,
may be further amplified by the abundant presence of these
cells within the renal cortex of the kidney.
In addition to a secreted form, we have found that TEC also
express a cytotoxic surface molecule which is related to TNFa.
This finding is consistent with similar data in macrophages [1,
201, but more interestingly indicates that membrane associated
cytokines are not limited to cells of hematopoietic origin. There
has been recent controversy concerning the membrane associ-
ation of IL-I, and the adequacy of fixation procedures [451. To
avoid potential artifact, we chose a rigorous fixation for one
hour with paraformaldehyde, followed by a prolonged incuba-
tion and extensive washes. Thus it is very unlikely that any of
Fig. 8. CI cells express a prominent 26 kD surface molecule related to
TNFa. Cl cells were incubated with LPS (2 tg/ml) for 12 hours, and
surface labelled with 1251. Cellular extracts were immuno-precipitated
with anti-TNFa antisera (lane I), or preimmune serum (lane 2). Size
markers (kD) and solvent front (SF) are indicated.
the effects we observed with fixed cells were due to simple
leakage of cytoplasmic proteins.
The observation that the membrane associated cytotoxicity
on TEC is related to TNFa is supported by several findings.
Firstly, cytotoxicity is increased by LPS or IL-la, which
individually can induce TNFa mRNA [7, 12]. Secondly, cyto-
toxicity is blocked specifically by anti-TNFa antisera which
identifies recombinant mouse TNFa. Thirdly, cell surface la-
belling of TEC identifies a prominent 26 kD molecule, which
has been shown to represent the surface form of TNFa in other
cells, and is the size predicted by the cDNA sequence if the
leader peptide is not cleaved [20]. Several larger molecular
weight (Mr> 40 kD) bands seen with our surface or metabolic
labelling, have been noted in similar studies of T cells and may
represent multimeric forms of TNFa [2, 46]. The presence of
prominent bands at 40 to 45 kD using 3H-leucine metabolic
labelling, which were blocked with unlabelled TNFa, suggests
that they are also antigenically related to TNF. It is interesting
that using a 3H metabolic label, we observed bands similar to
that observed with ovarian epithelial tumor cells using a similar
method [47], and that in contrast to 125j surface labelling, a 26
kD band was not seen. It is not clear if this discrepancy is due
to an increased stability of the 26 kD surface form using
lactoperoxidase or to a difference in the sensitivity of the
methods.
The regulation of TNFa is complex and involves both pre-
and post-transcriptional mechanisms. In non-transformed
smooth muscle cells, the expression of TNFa mRNA can only
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be induced by co-incubation with cycloheximide and LPS,
suggesting that repressor mechanisms normally prevent expres-
sion in these cells or that TNFa mRNA is rapidly degraded [8].
The short lived nature of many cytokine mRNA's is generally
due to A-U rich sequences in the 3' untranslated region [9]. In
contrast, macrophages express constitutive levels of TNFa
mRNA, but must be stimulated with LPS to secrete product. In
this regard, our data showing low level induction with LPS or
IL-la, and superinduction with IL-Ia or LPS plus cyclohexi-
mide suggests that TEC may be more similar to smooth muscle
cells. These data also indicate that transcriptional regulatory
mechanisms exist in TEC following SV4O DNA transformation.
To allow long-term studies of pure populations of cells, we
have used immortalized and cloned TEC transformed with
origin deficient SV4O DNA [7]. Since epithelial tumor cells may
express TNFa mRNA, the question arises if SV4O DNA
transformation alters normal cell function and imparts TNFa
producing capabilities to TEC [47—49]. However, in situ hybrid-
ization studies of C3H/FeJ mice indicate non-transformed TEC
have the capacity to express TNFa mRNA in response to LPS
stimulation in vivo. In our experience, immunohistochemistry
techniques have not been able to demonstrate tubular cell
TNFa in kidney cryosections from mice with autoimmune
nephritis or stimulated with LPS (unpublished observations).
This is not surprising considering the potentially low levels
expressed, the lability of this cytokine and the high levels of
endogenous peroxidase activity in kidney tubules which could
obscure detection of low levels by standard techniques. It is
also possible that additional post-transcriptional factors control
translation of TNFa mRNA in these cells in vivo.
Since the expression of TNFa is influenced by LPS, we
screened our media for endotoxin contamination by Limulus
assays. Although these assays are sensitive, the potential
contribution of trace amounts of LPS to TNFa production
basally or in response to IL-la, cannot be entirely excluded
[38]. However, we have not detected other endotoxin inducible
TEC products, such as MHC and adhesion molecules (ICAM-
1), at concentrations below what can be detected by Limulus
screening (<25 pg/mI). Also, TNFa is not induced in TEC by
other cytokine preparations (TNFa, IFN-y, IL-4), which would
be equally susceptible to endotoxin contamination [7]. Alterna-
tively, low levels of endotoxin contamination may have caused
some desensitization of tubular cells to further stimulation and
TNFa production. This may account for the decreased TNFa
inducibility we have noted in cell lines that have been exten-
sively passaged [39].
The physiological relevance of secreted or membrane asso-
ciated cytokine production by TEC is unknown, particularly
when the amounts are small. TNFa may modulate immune
responses locally and act as a costimulatory factor for T cells
[14, 15]. It is interesting to note that an earlier report identified
a "IL-l-like" thymocyte stimulating factor in the supernatant
of LPS stimulated TEC [23], and that TNFa has recently been
demonstrated to have thymocyte co-stimulatory actions [16].
Alternatively, TNFa may indirectly function as a growth factor
by increasing EGF receptors which are present on TEC [50].
Several groups have also noted that an inverse relationship
exists between TNF production, and TNF sensitivity [48, 49].
This raises the intriguing possibility that in addition to focussing
its pro-inflammatory action on adjacent cells, the expression of
TNFa by TEC, may confer some protection against its own
toxic properties. These results suggest that a role exists for
TNFa production by non-hematopoietic cells within the kidney
and highlight the complexity of TNFa involvement in mediating
renal injury.
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